Blue dye gel shows promise for treating inoperable skin cancer
NCT ID NCT07311057
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a special blue dye gel (methylene blue) can safely shrink skin cancer tumors and help wounds heal in people who cannot have surgery or radiation. About 20 adults with advanced squamous cell carcinoma will apply the gel every two days for a month, followed by a healing gel. Researchers will track tumor size and safety for six months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INOPERABLE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mashhad University of Medical Sciences
Mashhad, Razavi Khorasan Province, Iran
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New rectal cancer device tested in elderly patients
- Blue dye cream takes on tough skin cancer in new trial
- Blood test may predict cancer recurrence in head and neck patients
- New scanner could help surgeons remove all cancer in one go
- New triple-drug attack aims to revive immune response in hard-to-treat melanoma
- New virus therapy takes on advanced cancers in first human trial